We just received data on a new analyst forecast for $ECL. Patrick Cunningham from Citigroup set a price target of 315.0 for ECL.
To track analyst ratings and price targets for $ECL, check out Quiver Quantitative's $ECL forecast page.
Should you buy $ECL?
Some analysts are better than others. To view the past performance of Citigroup, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$ECL Price Targets
Multiple analysts have issued price targets for $ECL recently. We have seen 10 analysts offer price targets for $ECL in the last 6 months, with a median target of $300.0.
Here are some recent targets:
- Patrick Cunningham from Citigroup set a target price of $315.0 on 12/18/2025
- Stephen Richardson from Evercore ISI Group set a target price of $300.0 on 11/03/2025
- Joshua Spector from UBS set a target price of $291.0 on 10/31/2025
- Manav Patnaik from Barclays set a target price of $300.0 on 10/29/2025
- Jeffrey Zekauskas from JP Morgan set a target price of $265.0 on 10/29/2025
- Shlomo Rosenbaum from Stifel set a target price of $300.0 on 10/29/2025
- Jason Haas from Wells Fargo set a target price of $270.0 on 10/27/2025
$ECL Insider Trading Activity
$ECL insiders have traded $ECL stock on the open market 7 times in the past 6 months. Of those trades, 2 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $ECL stock by insiders over the last 6 months:
- CHRISTOPHE BECK (CHAIRMAN & CEO) has made 0 purchases and 2 sales selling 21,714 shares for an estimated $5,676,232.
- SUZANNE M VAUTRINOT sold 1,354 shares for an estimated $383,401
- BOO ALEXANDER A. DE (EVP & PRES - GLOBAL MARKETS) sold 1,422 shares for an estimated $381,451
- DAVID MACLENNAN has made 2 purchases buying 1,350 shares for an estimated $360,305 and 0 sales.
- JENNIFER J BRADWAY (SVP & CORPORATE CONTROLLER) sold 807 shares for an estimated $225,378
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ECL Revenue
$ECL had revenues of $4.2B in Q3 2025. This is an increase of 4.16% from the same period in the prior year.
You can track ECL financials on Quiver Quantitative's ECL stock page.
$ECL Congressional Stock Trading
Members of Congress have traded $ECL stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $ECL stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$ECL Hedge Fund Activity
We have seen 754 institutional investors add shares of $ECL stock to their portfolio, and 775 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP removed 3,043,674 shares (-64.6%) from their portfolio in Q3 2025, for an estimated $833,540,561
- JPMORGAN CHASE & CO added 2,889,475 shares (+80.2%) to their portfolio in Q3 2025, for an estimated $791,311,623
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 2,830,425 shares (+70.3%) to their portfolio in Q3 2025, for an estimated $775,140,190
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,718,268 shares (+369.1%) to their portfolio in Q3 2025, for an estimated $470,564,874
- CANTILLON CAPITAL MANAGEMENT LLC removed 1,016,637 shares (-92.8%) from their portfolio in Q3 2025, for an estimated $278,416,208
- NORGES BANK added 920,419 shares (+41.4%) to their portfolio in Q2 2025, for an estimated $247,997,695
- BLACKROCK, INC. added 756,267 shares (+3.5%) to their portfolio in Q3 2025, for an estimated $207,111,280
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
